Varian ProBeam360° Proton Therapy System China Clinical Trial (Wuhan)

NARecruitingINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

August 29, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Tumor, Solid
Interventions
DEVICE

Proton Radiation Therapy

All enrolled participants will be treated with Proton radiation therapy using the medical device Varian ProBeam360° Proton Therapy System. The screening period from informed consent to enrollment is expected to be 4 weeks, while the treatment period is 1 to 8 weeks. The period after the last treatment is divided into short-term follow-up which is 3 months after treatment completion and long-term follow-up which is 5 years after treatment completion.

Trial Locations (1)

Unknown

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

All Listed Sponsors
lead

Varian, a Siemens Healthineers Company

INDUSTRY